Abstract
The aim of the present case-control study was to ascertain whether, in adults, yearly repeated anti-influenza vaccinations (AIV) enhance protection against cutaneous melanoma (CM), as do repeated febrile infections. Ninety-nine new cases of histologically confirmed CM and 104 healthy controls (matched to cases for sex, age, and skin colour) selected from the general population were examined in order to ascertain their skin type, the number of nevi on both arms, and the intensity of freckles on the face and the arms; in these subjects, a structured questionnaire was used to obtain information on age, sex, education, social class, exposure and susceptibility to sunlight, history of febrile infectious diseases, and vaccinations. The odds ratio (OR) and the 95% confidence interval (CI) were estimated by commonly used methods and by fitting models of logistic regression. The risk of CM was reduced in subjects with a history of febrile (temperature above 38.5 °C) infections in the 5 years prior to CM surgery (cases) or interview (controls), but was increased in those with voluntary exposure to sunlight in tropical countries. By holding the above factors constant at logistic regression analysis, it was found that a history of repeated AIV (3–5 times in the last 5 years) halved the risk (OR: 0.43; CI: 0.19–1.00; p < 0.05). With the variable `nevi on arms' included, the protective influence of repeated AIVs was observed in a similar magnitude. The inverse relationship found between melanoma and influenza vaccinations is unlikely to have depended on a bias, even if based on replies in a questionnaire, because neither the interviewers nor the interviewers were informed in advance of the working hypothesis.
Similar content being viewed by others
References
Bouwes-Bavinck JN, Hardie DR, Green A, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation 1996; 61: 715–721.
Euvrard S, Kanitakis J, Pouteil-Noble C, Claudy A, Touraine JL. Skin cancers in organ transplant recipients. Ann-Transplant 1997; 2: 28–32.
Veness MJ, Quinn DI, Ong CS, et al. Aggressive cutaneous malignancies following cardiothoracic transplantation: The Australian experience. Cancer 1999; 85: 1758–1764.
Morison WL, Baughman RD, Day RM, et al. Consensus workshop on the toxic effects of long-term PUVA therapy. Arch-Dermatol 1998; 134: 595–598.
Autier P, Dore JF, Lejeune F, et al. Cutaneous malignant melanoma and exposure to sunlamps or sunbeds: An EORTC multicenter case-control study in Belgium, France and Germany. EORTC Melanoma Cooperative Group. Int J Cancer 1994; 58: 809–813.
Elwood JM, Jopson J. Melanoma and sun exposure: An overview of published studies. Int J Cancer 1997; 73: 198–203.
Gilchrest BA, Eller MS, Geller AC, Yaar M. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med 1999; 340: 1341–1348.
Harwood CA, Spink PJ, Surentheran T, et al. Detection of human papilloma virus DNA in PUVA-associated non-melanoma skin cancers. J Invest Dermatol 1998; 111: 123–127.
Stern RS, Nichols KT, Vakeva LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA follow-up study. N Engl J Med 1997; 336: 1041–1045.
Maurer S, Kolmel KF. Spontaneous regression of malignant melanoma. Monograph 19, Cancer research Institute, New York, 1997.
Kolmel KF, Gefeller O, Haferkamp B. Febrile infections and malignant melanoma: Results of a case-control study. Melanoma Res 1992; 2: 207–211.
Kölmel KF, Pfalhberg A, Mastrangelo G, et al. Infections and melanoma risk: Results of a multicentre EORTC case-control study. Melanoma Res 1999; 9: 511–519.
Mackowiak PA, Bartlett JG, Borden EC, et al. Concepts of fever: Recent advances and lingering dogma. Clin-Infect-Dis 1997; 25: 119–138.
Abel U, Becker N, Angerer R, et al. Common infections in the history of cancer patients and controls. J Cancer Res Clin Oncol 1991; 117: 339–344.
Breslow NE, Day NE. Statistical methods in cancer research. Vol. I of the analysis of case-control studies. Lyon: IARC Sci Pub, 1980.
Dixon WJ (ed). BMDP Statistical Software Manual, Berkeley, University of California Press, 1992.
Elwood JM, Gallagher RP. Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure. Int J Cancer 1998; 78: 276–280.
Ambrosch F, Wiedermann G, Krepler P. BCG vaccination and leukemia in Austria. Epidemiological and clinical studies. In: Crispen R, (ed) Cancer: Etiology and prevention. Chicago Symposium, 1982 Oct 4–6, Amsterdam: Elsevier Science Publishing, 1983: 387–398.
Katz L, Steinitz R. BCG vaccination of newborns and incidence of childhood leukemia in Israel. In: Crispen R, (ed) Cancer: Etiology and prevention. Chicago Symposium, 1982 Oct 4–6, Amsterdam: Elsevier Science Publishing, 1983: 383–386.
Lamm DL, Van der Maijden APM, Steg A, et al. BCG immunotherapy of superficial bladder cancer: Treatment, results, risks, and complications. 15th International Cancer Congress, 1990 Aug 16–22, Hamburg. J Cancer Res Clin Oncol 1990; 116 Vol. Abstracts.
Kurth KH. Diagnosis and treatment of superficial transitional cell carcinoma of the bladder: Facts and perspectives. Eur-Urol 1997; 31 (suppl. 1): 10–19.
Gruffermann S, Wang HH, Delong ER, Kimm SYS, Delzell ES, Faletta JM. Environmental factors in the etiology of rhabdomyosarcoma in childhood. J Natl Cancer Inst 1982; 68: 107–113.
Mastrangelo G, Marzia V, Marcer G. Reduced lung cancer mortality in dairy farmers: Is endotoxin exposure the key factor? Am J Ind Med 1996; 30: 601–609.
Yamakido M, Ishioka S, Hiyama K, Maeda A. Former poison gas workers and cancer: Incidence and inhibition of tumor formation by treatment with biological response modifier N-CWS. Environ-Health-Perspect 1996; 104 (Suppl. 3): 485–488.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mastrangelo, G., Rossi, C., Pfahlberg, A. et al. Is there a relationship between influenza vaccinations and risk of melanoma? A population-based case-control study. Eur J Epidemiol 16, 777–782 (2000). https://doi.org/10.1023/A:1007658503740
Issue Date:
DOI: https://doi.org/10.1023/A:1007658503740